Conditions: Schizophrenia
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 10
Healthy volunteers: no

Brief summary:
This is a four week open label trial of ALLOPURINOL to the treatment regime of ten (10) poorly responsive patients with schizophrenia, monitoring their response and side-effects. No change in medication is required.

Detailed description:

Arms:
arm 1: Allopurinal 300mg once daily by mouth for four weeks

Interventions: intervention 1: Allopurinal
Intervention descriptions: intervention 1: 300mg once daily by mouth for four weeks

Protocol document: